We investigated whether transverse aortic constriction (TAC)-induced pressure overload caused Ca2+ leak through ryanodine receptor (RyR2) even in compensated pressure-overloaded hearts, and whether chronic administration of dantrolene, a RyR2 stabilizer, inhibited the cardiomyocyte hypertrophy and dysfunction by stopping the Ca2+leak. Methods: We developed compensated hypertrophy model by 2 weeks-TAC in mice. TAC mice were divided into dantrolene-treated (DAN) group and vehicle (non-DAN) group. Then, cardiomyocytes were isolated from hearts, and diastolic Ca2+ spark assay, simultaneous Ca2+ transient (CaT) and cell shortening (CS) assay were examined. Results: Ca2+ leak through RyR2 was observed even in the early compensated pressure-overloaded heart. Two weeks-TAC caused cardiomyocyte hypertrophy, which was inhibited by chronic dantrolene administration. Ca2+ spark frequency (CaSF) was higher in TAC than in Sham, which was inhibited by chronic dantrolene treatment. %CS and time to peak as an index of contractility were normally preserved in both DAN and non-DAN groups. However, time from peak to 70% decline as an index of relaxation was significantly longer in non-DAN group than in DAN group. Conclusions: Dantrolene restores the cardiomyocyte dysfunction and inhibits the cardiomyocyte hypertrophy by inhibiting the aberrant Ca2+ leak through RyR2 in the compensated pressure-overloaded heart.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Cardiac Failure
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect